XIth Eurasian Hematology-Oncology Congress - EHOC 2020

 

Benign Hematology
27:49

XIth Eurasian Hematology-Oncology Congress - EHOC 2020

Haploidentical Transplant in Developing Countries: Challenges, Modern Strategies (T-Cell Depletion, GIAC, PTCy), Donor Selection, DSA, Relapse

FEATURING Gulsun Karasu
  • 19 views
  • January 18, 2021
23:18

XIth Eurasian Hematology-Oncology Congress - EHOC 2020

Curative Options for Hemoglobinopathies: Is MSD the SoC in Thalassemia and Sickle Cell Disease Compared to MUD and Haploidentical HSCT?

FEATURING Selim Corbacioglu
  • 43 views
  • January 18, 2021
12:45

XIth Eurasian Hematology-Oncology Congress - EHOC 2020

Anti-T Cell pAbs for GVHD Prevention: Does the Addition of ATLG Grafalon to Standard Cyclosporin+Methotrexate Reduce cGVHD Incidence and Improve cGRFS?

FEATURING Francesca Bonifazi
  • 8 views
  • January 18, 2021
21:57

XIth Eurasian Hematology-Oncology Congress - EHOC 2020

Bone Marrow Failure: Aplastic Anemias, Telomere Diseases, GATA2 Deficiency, Eltrombopag & Cyclosporin for AA

FEATURING Rodrigo Calado
  • 61 views
  • January 15, 2021
14:49

XIth Eurasian Hematology-Oncology Congress - EHOC 2020

Infections in Immunocompromised Patients: Immunodeficiencies in Bone Marrow Failure, Febrile Neutropenia, MDR GN Bacteria, De-Escalation Approach

FEATURING Marcio Nucci
  • 30 views
  • January 15, 2021
19:30

XIth Eurasian Hematology-Oncology Congress - EHOC 2020

Paroxysmal Nocturnal Hemoglobinuria: Epidemiology, Classification, Risk of Thrombosis, Eculizumab/Ravulizumab Therapy

FEATURING Hanan Hamed
  • 23 views
  • January 15, 2021
03:38

XIth Eurasian Hematology-Oncology Congress - EHOC 2020

2 y/o With Ecchymoses, Hepatosplenomegaly and Cervical Lymphadenopathies: RAS-Related Lymphoproliferative Disorder

FEATURING Cagri Coskun
  • 17 views
  • January 15, 2021
14:22

XIth Eurasian Hematology-Oncology Congress - EHOC 2020

ASFA Guidelines on the Use of Therapeutic Apheresis: What Does the Guideline Preparation Incorporate? How Do the Guidelines Help in Clinical Practice?

FEATURING Nancy Dunbar
  • 19 views
  • January 12, 2021
19:17

XIth Eurasian Hematology-Oncology Congress - EHOC 2020

Managing Late Complications in Beta Thalassemia: Thrombotic Disease, Pulmonary Hypertension, Liver Disease, Extramedullary Haematopoiesis, Leg Ulcers, Kidney Disease, Endocrine/Bone Disease

FEATURING Valeh Huseynov
  • 25 views
  • January 12, 2021
23:20

XIth Eurasian Hematology-Oncology Congress - EHOC 2020

Sickle Cell Disease: Pathogenesis, When to Recommend MSD-SCT, Anticoagulants & Anti-Platelet Agents, Drugs Targeting Cell Adhesions and Inflammatory Pathways

FEATURING Salam Alkindi
  • 109 views
  • January 12, 2021
  • 1
23:55

XIth Eurasian Hematology-Oncology Congress - EHOC 2020

Hemophilia Treatment in Developing Countries: What Are the Principles?

FEATURING Bulent Antmen
  • 49 views
  • January 12, 2021
17:36

XIth Eurasian Hematology-Oncology Congress - EHOC 2020

ITP Updates: Which Immune Suppressants Should We Use? What Is the Effect of 2nd Gen TPO-RAs (Eltrombopag, Romiplostim, Avatrombopag)?

FEATURING Drew Provan
  • 103 views
  • January 11, 2021
  • 1